Cardiac Marker Diagnostic Testing Market Analysis 2010-2020 with Industry Chain Structure, Competitive Landscape

Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies.

Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets.

Request For Sample of this Report available at http://www.reportsnreports.com/contacts/RequestSample.aspx?name=75186

Major Points From Table of Contents

1. Overview 8

2. The Basics of Biomarkers 14

3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and Share 21

4. Cardiovascular Disease Markers 93

5. Cardiac Marker Testing Development Issues 108

6. Business Trends in the Industry 124

7. Important Technology Trends 150

List of Figures

Figure 3.1: Market Share of Cardiac Marker Segment 27

Figure 3.2: U.S. Cardiac Marker Diagnostic Testing Market Segments, 2016 29

Figure 3.3: U.S. POC Cardiac Marker Sales, 2011-2021 30

Figure 3.4: Cardiac Marker Market for Diagnostic Testing in Europe, 2011-2021 32

Figure 3.5: Cardiac Marker POCT Troponin Market Share by Product Type 87

Figure 3.6: Cardiac Marker POCT BNP Market Share by Product Type 87

Figure 4.1: Prevalence of Total Cholesterol Among Adults Aged 20 and Over, by Sex and Age in the U.S., 2011-2014 94

Figure 4.2: Age-Adjusted Trends in Prevalence of High total and low HDL Cholesterol Among Adults Aged over 20 in the U.S., 1999-2014 95

Figure 4.3: Prevalence of Cholesterol Screening in Adults Ages =20, U.S. 96

Figure 5.1: CLIA Laboratories by Certificate Types, 2016 120

Figure 6.1: Current Conformity Assessment Route, Annexes and Quality System Standards by IVD Device Category 135

Figure 6.2: The Chinese Healthcare System 143

Purchase This Report Online at http://www.reportsnreports.com/Purchase.aspx?name=75186

About Us:
ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 500,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements – first time and every time!

Contact Us:
[email protected]

+ 1 888 391 5441